Use of “Biosimilar” Insulins for Diabetes (June 2019)
Summary This Position Statement represents the collective views of the Australian Diabetes Society, the Australian Diabetes Educators Association and Diabetes Australia. The Therapeutic Goods Administration (TGA) recently approved the first